Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy
Prostate Cancer
About this trial
This is an interventional diagnostic trial for Prostate Cancer focused on measuring Positron Emission Tomography Computed Tomography, Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC)), Biopsy
Eligibility Criteria
Inclusion Criteria:
i. Clinically or biochemically suspected cases of Ca Prostate. ii. Patients with PSMA avid lesion in the prostate iii. Patients, who were ready to give written informed consent for biopsy iv. In good general condition (Karnofsky performance status, KPS, of more than 70).
Exclusion Criteria:
i. No focal PSMA expressing lesion in the prostate ii. Patients who refused to give written informed consent iii. Abnormal coagulation profile iv. Acute prostatitis, any severe acute or chronic medical condition
Sites / Locations
- Department of Nuclear Medicine, PGIMER
Arms of the Study
Arm 1
Experimental
PSMA PET/CT guided biopsy arm
Ga-68 PSMA PET/CT imaging is now routinely done in patients with prostate cancer with biochemical recurrence, response evaluation and even in patients with clinical suspicion of prostate cancer. In the present study, we aim to plan robotic arm-assisted Ga-68 PSMA guided transgluteal prostatic biopsies.